Annual D&A
$4100.00
-$7700.00-65.25%
December 31, 2023
Summary
- As of February 7, 2025, CNSP annual depreciation & amortization is $4100.00, with the most recent change of -$7700.00 (-65.25%) on December 31, 2023.
- During the last 3 years, CNSP annual D&A has fallen by -$7000.00 (-63.06%).
- CNSP annual D&A is now -68.70% below its all-time high of $13.10 thousand, reached on December 31, 2021.
Performance
CNSP Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$800.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, CNSP quarterly depreciation & amortization is $800.00, unchanged on September 30, 2024.
- Over the past year, CNSP quarterly D&A has dropped by -$100.00 (-11.11%).
- CNSP quarterly D&A is now -77.14% below its all-time high of $3500.00, reached on December 31, 2021.
Performance
CNSP Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$3400.00
-$100.00-2.86%
September 30, 2024
Summary
- As of February 7, 2025, CNSP TTM depreciation & amortization is $3400.00, with the most recent change of -$100.00 (-2.86%) on September 30, 2024.
- Over the past year, CNSP TTM D&A has dropped by -$2200.00 (-39.29%).
- CNSP TTM D&A is now -74.81% below its all-time high of $13.50 thousand, reached on March 31, 2022.
Performance
CNSP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CNSP Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.3% | -11.1% | -39.3% |
| 3 y3 years | -63.1% | -76.5% | -73.2% |
| 5 y5 years | +100.0% | -76.5% | -73.2% |
CNSP Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.7% | at low | -77.1% | at low | -74.8% | at low |
| 5 y | 5-year | -68.7% | +105.0% | -77.1% | at low | -74.8% | +70.0% |
| alltime | all time | -68.7% | -100.0% | -77.1% | -100.0% | -74.8% | -100.0% |
CNS Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $800.00(0.0%) | $3400.00(-2.9%) |
| Jun 2024 | - | $800.00(0.0%) | $3500.00(-5.4%) |
| Mar 2024 | - | $800.00(-20.0%) | $3700.00(-11.9%) |
| Dec 2023 | $4100.00(-65.3%) | $1000.00(+11.1%) | $4200.00(-25.0%) |
| Sep 2023 | - | $900.00(-10.0%) | $5600.00(-25.3%) |
| Jun 2023 | - | $1000.00(-23.1%) | $7500.00(-22.7%) |
| Mar 2023 | - | $1300.00(-45.8%) | $9700.00(-17.8%) |
| Dec 2022 | $11.80 K(-9.9%) | $2400.00(-14.3%) | $11.80 K(-8.5%) |
| Sep 2022 | - | $2800.00(-12.5%) | $12.90 K(-4.4%) |
| Jun 2022 | - | $3200.00(-5.9%) | $13.50 K(0.0%) |
| Mar 2022 | - | $3400.00(-2.9%) | $13.50 K(+3.1%) |
| Dec 2021 | $13.10 K | $3500.00(+2.9%) | $13.10 K(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $3400.00(+6.3%) | $12.70 K(+1.6%) |
| Jun 2021 | - | $3200.00(+6.7%) | $12.50 K(+2.5%) |
| Mar 2021 | - | $3000.00(-3.2%) | $12.20 K(+9.9%) |
| Dec 2020 | $11.10 K(+455.0%) | $3100.00(-3.1%) | $11.10 K(+22.0%) |
| Sep 2020 | - | $3200.00(+10.3%) | $9100.00(+37.9%) |
| Jun 2020 | - | $2900.00(+52.6%) | $6600.00(+69.2%) |
| Mar 2020 | - | $1900.00(+72.7%) | $3900.00(+95.0%) |
| Dec 2019 | $2000.00(>+9900.0%) | $1100.00(+57.1%) | $2000.00(+122.2%) |
| Sep 2019 | - | $700.00(+250.0%) | $900.00(+350.0%) |
| Jun 2019 | - | $200.00(>+9900.0%) | $200.00(>+9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is CNS Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual D&A year-on-year change?
- What is CNS Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly D&A year-on-year change?
- What is CNS Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM D&A year-on-year change?
What is CNS Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CNSP is $4100.00
What is the all time high annual D&A for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual depreciation & amortization is $13.10 K
What is CNS Pharmaceuticals annual D&A year-on-year change?
Over the past year, CNSP annual depreciation & amortization has changed by -$7700.00 (-65.25%)
What is CNS Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CNSP is $800.00
What is the all time high quarterly D&A for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly depreciation & amortization is $3500.00
What is CNS Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CNSP quarterly depreciation & amortization has changed by -$100.00 (-11.11%)
What is CNS Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CNSP is $3400.00
What is the all time high TTM D&A for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM depreciation & amortization is $13.50 K
What is CNS Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CNSP TTM depreciation & amortization has changed by -$2200.00 (-39.29%)